The Division of Hematology/Oncology at the Icahn School of Medicine at Mount Sinai is seeking an individual to lead the section of hematology for the Mount Sinai Health System.
The Mount Sinai Health System (MSHS) is an integrated health care system providing exceptional medical care to local and global communities. Encompassing the Icahn School of Medicine at Mount Sinai and eight hospital campuses in the New York metropolitan area, as well as a large, regional ambulatory footprint, Mount Sinai is internationally acclaimed for its excellence in research, patient care, and education across a range of specialties. The applicant would join the faculty in the Division of Hematology/Oncology in the Department of Medicine at Mount Sinai, and have responsibility for oversight of patient care, clinical research, training and education programs involving benign hematology; the division currently includes approximately 120 faculty members, of whom 17 practice benign hematology
Hematology has a long and distinguished history at Mount Sinai, led by pioneers in the field including Nathan Rosenthal, Louis R.Wasserman, Barry S. Coller, and Ronald Hoffman, who currently leads the Myeloproliferative Disorder Research Program, funded by an NIH P01 grant. Early seminal scientific breakthroughs included the first observation of universal blood donor characteristics, the development of a method for storing blood for later transfusion, and the country’s first Intravenous Therapy Department, and one of the first blood banks in the country. There are currently funded programs in sickle cell disease, iron disorders, and hemophilia. In addition to benign hematology, the applicant would have the opportunity collaborate with others with expertise in malignant hematology at the Tisch Cancer Institute (TCI), a National Cancer Institute (NCI)-designated center. In addition to myeloproliferative disorders, TCI-investigators are internationally recognized for their expertise in multiple myeloma, leukemia, myelodysplasia, and stem cell transplantation/cellular therapy.
- Head, Section of Hematology
- Clinical Support staff: Nurse Practitioners, Registered Nurses, and Medical Assistants
- Administrative support staff
- EMR system: Epic
- Teaching and or research
- Competitive salary and benefits offered
- Medical Degree from an Accredited University
- New York Medical License
- Board Eligible or Board Certified in Hematology
- Associate professor or professor with established track record of accomplishment including patient care, scholarly activity, and clinical research
- Excellent communication, bedside manner, and organizational skills
- A system work ethic and desire to participate in a team-oriented, performance driven health system
About the Mount Sinai Health System:
The Mount Sinai Health System is New York City's largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai advances medicine and health through unrivaled education and translational research and discovery to deliver care that is the safest, highest-quality, most accessible and equitable, and the best value of any health system in the nation. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture ambulatory surgery centers; more than 415 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. The Mount Sinai Hospital is ranked on U.S. News & World Report's "Honor Roll" of the top 20 U.S. hospitals and is top in the nation by specialty: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, ENT, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. Mount Sinai Kravis Children's Hospital is ranked in U.S. News & World Report’s “Best Children’s Hospitals” among the country’s best in four out of 10 pediatric specialties. The Icahn School of Medicine is one of three medical schools that have earned distinction by multiple indicators: ranked in the top 20 by U.S. News & World Report's "Best Medical Schools," aligned with a U.S. News & World Report "Honor Roll" Hospital, and No. 14 in the nation for National Institutes of Health funding. Newsweek’s “The World’s Best Smart Hospitals” ranks The Mount Sinai Hospital as No. 1 in New York and in the top five globally, and Mount Sinai Morningside in the top 20 globally. For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.
The Mount Sinai Health System is an equal opportunity employer. We comply with applicable Federal civil rights laws and does not discriminate, exclude, or treat people differently on the basis of race, color, national origin, age, religion, disability, sex, sexual orientation, gender identity, or gender expression.
Please address letter of interest to:
Joseph Sparano, MD, Chief of Hematology/Oncology, Deputy Director, Tisch Cancer Institute
Please send Letter of Interest and CV to:
Executive Director Physician Recruitment
Mount Sinai Health System